Pre-treatment agent and pre-treatment method for antithrombin III to be subjected to limulus test

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10132812
APP PUB NO 20160061838A1
SERIAL NO

14758269

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

To provide means for reducing reaction interference observed when AT III is subjected to limulus test, whereby the limulus test of antithrombin III can be carried out at high accuracy. Reaction interference observed when AT III is subjected to limulus test can be reduced by subjecting AT III to a protein inactivation treatment in the co-presence of a divalent metal salt.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SEIKAGAKU CORPORATION6-1 MARUNOUCHI 1-CHOME CHIYODA-KU TOKYO 100-0005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aizawa, Maki Tokyo, JP 9 14
Aketagawa, Jun Tokyo, JP 10 98
Oda, Toshio Tokyo, JP 33 156

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 20, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 20, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00